All Stories

  1. Cultural assimilation of adult Syrian refugees in Lebanon: Effect modification by religiosity and sex on the relation between cultural adversities and common mental health disorders.
  2. Estrogen Receptor and the Gender Bias in Raynaud’s Phenomenon
  3. Posttraumatic stress disorder among the Lebanese population and Syrian refugees: A systematic review.
  4. Cannabinoids and Myocardial Ischemia: Novel insights, Updated Mechanisms, and Implications for Myocardial Infarction
  5. Inflammatory Basis of Atherosclerosis: Modulation by Sex Hormones
  6. Modulation of proteomic and inflammatory signals by Bradykinin in podocytes
  7. Serum Glycomics Profiling of Patients with Primary Restless Legs Syndrome Using LC–MS/MS
  8. Circulating Brain Injury Exosomal Proteins following Moderate-to-Severe Traumatic Brain Injury: Temporal Profile, Outcome Prediction and Therapy Implications
  9. Location of neonatal microglia drives small extracellular vesicles content and biological functions in vitro
  10. Transcriptomic profiling of trophoblast fusion using BeWo and JEG-3 cell lines
  11. PC1/3 KD Macrophages Exhibit Resistance to the Inhibitory Effect of IL-10 and a Higher TLR4 Activation Rate, Leading to an Anti-Tumoral Phenotype
  12. Novel Peptidomic Approach for Identification of Low and High Molecular Weight Tauopathy Peptides Following Calpain Digestion, and Primary Culture Neurotoxic Challenges
  13. Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging of Lipids in Experimental Model of Traumatic Brain Injury Detecting Acylcarnitines as Injury Related Markers
  14. Hydrogels for Advanced Stem Cell Therapies: A Biomimetic Materials Approach for Enhancing Natural Tissue Function
  15. A shared comparison of diabetes mellitus and neurodegenerative disorders
  16. LC-MS/MS glycomics of idiopathic rapid eye movement sleep behavior disorder
  17. Lipid Changes Associated with Traumatic Brain Injury Revealed by 3D MALDI-MSI
  18. SLC35B4, an Inhibitor of Gluconeogenesis, Responds to Glucose Stimulation and Downregulates Hsp60 among Other Proteins in HepG2 Liver Cell Lines
  19. Insomnia in hospitalized psychiatric patients: prevalence and associated factors
  20. Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification
  21. Glycosylation Changes in Brain Cancer
  22. Traumatic brain injury, diabetic neuropathy and altered-psychiatric health: The fateful triangle
  23. Preclinical modelling of militarily relevant traumatic brain injuries: Challenges and recommendations for future directions
  24. Combined Mass Spectrometry Imaging and Top-down Microproteomics Reveals Evidence of a Hidden Proteome in Ovarian Cancer
  25. Multitargeted Flavonoid Inhibition of the Pathogenic Bacterium Staphylococcus aureus: A Proteomic Characterization
  26. Thyroxine (T4) Transfer from Blood to Cerebrospinal Fluid in Sheep Isolated Perfused Choroid Plexus: Role of Multidrug Resistance-Associated Proteins and Organic Anion Transporting Polypeptides
  27. Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients
  28. The Application of Proteomics to Traumatic Brain and Spinal Cord Injuries
  29. Chemosensitivity of U251 Cells to the Co-treatment of D-Penicillamine and Copper: Possible Implications on Wilson Disease Patients
  30. Novel Bioinformatics–Based Approach for Proteomic Biomarkers Prediction of Calpain-2 & Caspase-3 Protease Fragmentation: Application to βII-Spectrin Protein
  31. Glycoproteins Enrichment and LC-MS/MS Glycoproteomics in Central Nervous System Applications
  32. Acute Exposure to Cigarette Smoking Followed by Myocardial Infarction Aggravates Renal Damage in an In Vivo Mouse Model
  33. Functional, Cellular, and Molecular Remodeling of the Heart under Influence of Oxidative Cigarette Tobacco Smoke
  34. AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study
  35. Biofluid Proteomics and Biomarkers in Traumatic Brain Injury
  36. Degradomics in Neurotrauma: Profiling Traumatic Brain Injury
  37. Effect of Second-Hand Tobacco Smoke on the Nitration of Brain Proteins: A Systems Biology and Bioinformatics Approach
  38. Efficient and Accurate Algorithm for Cleaved Fragments Prediction (CFPA) in Protein Sequences Dataset Based on Consensus and Its Variants: A Novel Degradomics Prediction Application
  39. Neuroproteomics Studies: Challenges and Updates
  40. Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats
  41. Cigarette Smoking-Induced Cardiac Hypertrophy, Vascular Inflammation and Injury Are Attenuated by Antioxidant Supplementation in an Animal Model
  42. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification
  43. Epidemiology and clinical characteristics of traumatic brain injury in Lebanon
  44. Deciphering the Role of Emx1 in Neurogenesis: A Neuroproteomics Approach
  45. Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk
  46. Restless leg syndrome in hospitalized psychiatric patients in Lebanon: a pilot study
  47. The kinetics of angiotensin-I metabolism in human carotid atheroma: An emerging role for angiotensin (1–7)
  48. Proteomic Analysis of the Spatio-temporal Based Molecular Kinetics of Acute Spinal Cord Injury Identifies a Time- and Segment-specific Window for Effective Tissue Repair
  49. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury
  50. Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study
  51. The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats
  52. Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma
  53. Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients
  54. Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment
  55. Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines
  56. Inflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia
  57. RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism
  58. Application of Systems Biology to Neuroproteomics: The Path to Enhanced Theranostics in Traumatic Brain Injury
  59. Postnatal Neural Stem Cells in Treating Traumatic Brain Injury
  60. Role of Systems Biology in Brain Injury Biomarker Discovery: Neuroproteomics Application
  61. Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells
  62. Mechanical stretch-induced vascular hypertrophy occurs through modulation of leptin synthesis-mediated ROS formation and GATA-4 nuclear translocation
  63. Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study
  64. Culture of PC12 neuronal cells in GelMA hydrogel for brain tissue engineering
  65. Correction: Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment
  66. Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment
  67. Cleaved Fragments Prediction Algorithm (CFPA) application to calpain and caspase in apoptosis and necrotic cell death
  68. Proteomics studies in inner ear disorders: pathophysiology and biomarkers
  69. Biomarker Identification in Psychiatric Disorders
  70. Autoantibodies in traumatic brain injury and central nervous system trauma
  71. Nanotheragnostic Applications for Ischemic and Hemorrhagic Strokes: Improved Delivery for a Better Prognosis
  72. CSF and Plasma Amyloid-β Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury
  73. Minor and Repetitive Head Injury
  74. Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions
  75. Recent updates on drug abuse analyzed by neuroproteomics studies: Cocaine, Methamphetamine and MDMA
  76. Human Traumatic Brain Injury Induces Autoantibody Response against Glial Fibrillary Acidic Protein and Its Breakdown Products
  77. A neuroproteomic and systems biology analysis of rat brain post intracerebral hemorrhagic stroke
  78. Post-Genomics Nanotechnology Is Gaining Momentum: Nanoproteomics and Applications in Life Sciences
  79. Stem cells in neuroinjury and neurodegenerative disorders: challenges and future neurotherapeutic prospects
  80. Bioinformatics Approach to Understanding Interacting Pathways in Neuropsychiatric Disorders
  81. Uses and challenges of bioinformatic tools in mass spectrometric-based proteomic brain perturbation studies
  82. Combining Biochemical and Imaging Markers to Improve Diagnosis and Characterization of Mild Traumatic Brain Injury in the Acute Setting: Results from a Pilot Study
  83. CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat
  84. Biomarkers Track Damage after Graded Injury Severity in a Rat Model of Penetrating Brain Injury
  85. The Challenge of Mild Traumatic Brain Injury: Role of Biochemical Markers in Diagnosis of Brain Damage
  86. An updated overview of animal models in neuropsychiatry
  87. Overpressure blast-wave induced brain injury elevates oxidative stress in the hypothalamus and catecholamine biosynthesis in the rat adrenal medulla
  88. Biomarkers in psychiatry: how close are we?
  89. Assessing neuro-systemic & behavioral components in the pathophysiology of blast-related brain injury
  90. Pilot Study Using Proteomics to Identify Predictive Biomarkers of Necrotizing Enterocolitis from Buccal Swabs in Very Low Birth Weight Infants
  91. Editorial
  92. In vitro MS-based proteomic analysis and absolute quantification of neuronal-glial injury biomarkers in cell culture system
  93. Microbial cell components induced tolerance to flagellin-stimulated inflammation through Toll-like receptor pathways in intestinal epithelial cells
  94. Proteomic analysis and brain-specific systems biology in a rodent model of penetrating ballistic-like brain injury
  95. Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma
  96. Global Renal Gene Expression Profiling Analysis in B2-Kinin Receptor Null Mice: Impact of Diabetes
  97. Anesthetic Management in Body Countouring Surgery
  98. Methods in Drug Abuse Models: Comparison of Different Models of Methamphetamine Paradigms
  99. Methods in Tobacco Abuse: Proteomic Changes Following Second-Hand Smoke Exposure
  100. Qualitative Versus Quantitative Methods in Psychiatric Research
  101. Protein Biomarkers for Traumatic and Ischemic Brain Injury: From Bench to Bedside
  102. Identification of tyrosine nitration in UCH-L1 and GAPDH
  103. Engineered Multifunctional Nanotools for Biological Applications
  104. Dual Vulnerability of Tau to Calpains and Caspase-3 Proteolysis Under Neurotoxic and Neurodegenerative Conditions
  105. Pharmacological Therapeutics for Detoxification in Addictive Disorders
  106. Food Addiction and Obesity: Evidence from Bench to Bedside
  107. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats
  108. Acute NMDA toxicity in cultured rat cerebellar granule neurons is accompanied by autophagy induction and late onset autophagic cell death phenotype
  109. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats
  110. Methods in Systems Biology of Experimental Methamphetamine Drug Abuse
  111. Systems Biology and Theranostic Approach to Drug Discovery and Development to Treat Traumatic Brain Injury
  112. Methamphetamine- and Trauma-Induced Brain Injuries: Comparative Cellular and Molecular Neurobiological Substrates
  113. Gliotypic Neural Stem Cells Transiently Adopt Tumorigenic Properties During Normal Differentiation
  114. Calmodulin-Binding Proteome in the Brain
  115. Methods in Drug Abuse Neuroproteomics: Methamphetamine Psychoproteome
  116. Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation
  117. Psychoproteomic Analysis of Rat Cortex Following Acute Methamphetamine Exposure
  118. Psychiatric research: psychoproteomics, degradomics and systems biology
  119. Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats
  120. Speed, Cocaine, and Other Psychostimulants Death Rates
  121. Performance Enhancing, Non-Prescription Use of Ritalin
  122. Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA
  123. Calpain-Mediated Collapsin Response Mediator Protein-1, -2, And -4 Proteolysis after Neurotoxic And Traumatic Brain Injury
  124. Application of the data mining techniques to the systems biology of neuritogenesis
  125. Novel neuroproteomic approaches to studying traumatic brain injury
  126. Ecstasy Toxicity
  127. Performance Enhancement and Adverse Consequences of MDMA
  128. Calpain- and caspase-mediated αII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure
  129. Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats
  130. Direct Rho-associated kinase inhibiton induces cofilin dephosphorylation and neurite outgrowth in PC-12 cells
  131. Neuroproteomics in neurotrauma
  132. Concurrent calpain and caspase-3 mediated proteolysis of αII-spectrin and tau in rat brain after methamphetamine exposure: A similar profile to traumatic brain injury
  133. A Multidimensional Differential Proteomic Platform Using Dual-Phase Ion-Exchange Chromatography−Polyacrylamide Gel Electrophoresis/Reversed-Phase Liquid Chromatography Tandem Mass Spectrometry
  134. Rapid Discovery of Putative Protein Biomarkers of Traumatic Brain Injury by SDS–PAGE–Capillary Liquid Chromatography–Tandem Mass Spectrometry
  135. Proteomics Studies of Traumatic Brain Injury
  136. SOME IMMUNOLOGICAL ASPECTS OF PATIENTS WITH RHINITIS IN LEBANON
  137. Major histocompatibility complex class I and II antigens frequencies in selected groups of Lebanese